JOHNSON & JOHNSON is 207.7x more valuable than SOLENO THERAPEUTICS INC by market capitalization ($573.98 B vs $2.76 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SLNO | JNJ |
|---|---|---|
| Market cap | $2.76 B | $573.98 B |
| US-listed rank | #1873 | #20 |
| Revenue (latest FY) | $1.45M | $94.19B |
| Net income (latest FY) | $20.89M | $26.80B |
| Net margin | 1439.9% | 28.5% |
| P/E (trailing FY) | 132.3 | 21.4 |
| SEC filings | 1,119 | 984 |
JOHNSON & JOHNSON is 207.7x more valuable than SOLENO THERAPEUTICS INC by market capitalization ($573.98 B vs $2.76 B).
In their latest fiscal years, SOLENO THERAPEUTICS INC reported $1.45M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: SOLENO THERAPEUTICS INC and JOHNSON & JOHNSON, or browse the full rankings.